PMDI (Psychemedics) Cyclically Adjusted Revenue per Share: $6.52 (As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PMDI Psychemedics Corp PMDI
58 GF Score
Price $2.49
View Full Analysis

What is Psychemedics Cyclically Adjusted Revenue per Share?

Psychemedics PMDI +13.18% 58 Cyclically Adjusted Revenue per Share is $6.52 as of Dec. 2024. GuruFocus rates PMDI with a GF Score™ of 58/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Psychemedics's adjusted revenue per share for the three months ended in Dec. 2024 was $0.739. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $6.52 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-25), Psychemedics's current stock price is $2.49. Psychemedics's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was $6.52. Psychemedics's Cyclically Adjusted PS Ratio of today is 0.38.


Psychemedics  (OTCPK:PMDI) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Psychemedics's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2.49/6.52
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Psychemedics Cyclically Adjusted Revenue per Share Related Terms


Psychemedics Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Psychemedics's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Psychemedics Cyclically Adjusted Revenue per Share Chart

Psychemedics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.19 6.51 6.76 6.71 6.52

Psychemedics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.71 6.75 6.69 6.61 6.52

PMDI vs MBAI, MYNZ, ADVB: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, Psychemedics's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Psychemedics Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Psychemedics's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Psychemedics's Cyclically Adjusted PS Ratio falls into.


PMDI
58GF Score
Psychemedics Corp PMDI
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Psychemedics Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Psychemedics's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.739/315.6050*315.6050
=0.739

Current CPI (Dec. 2024) = 315.6050.

Psychemedics Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 1.251 236.119 1.672
201506 1.295 238.638 1.713
201509 1.306 237.945 1.732
201512 1.130 236.525 1.508
201603 1.229 238.132 1.629
201606 1.779 241.018 2.330
201609 2.150 241.428 2.811
201612 1.947 241.432 2.545
201703 1.845 243.801 2.388
201706 1.748 244.955 2.252
201709 1.806 246.819 2.309
201712 1.762 246.524 2.256
201803 1.968 249.554 2.489
201806 1.942 251.989 2.432
201809 1.983 252.439 2.479
201812 1.796 251.233 2.256
201903 1.774 254.202 2.203
201906 1.682 256.143 2.072
201909 1.786 256.759 2.195
201912 1.580 256.974 1.940
202003 1.366 258.115 1.670
202006 0.600 257.797 0.735
202009 0.936 260.280 1.135
202012 0.965 260.474 1.169
202103 1.012 264.877 1.206
202106 1.082 271.696 1.257
202109 1.186 274.310 1.365
202112 1.155 278.802 1.307
202203 1.153 287.504 1.266
202206 1.161 296.311 1.237
202209 1.156 296.808 1.229
202212 1.007 296.797 1.071
202303 1.031 301.836 1.078
202306 0.969 305.109 1.002
202309 0.991 307.789 1.016
202312 0.861 306.746 0.886
202403 0.923 312.332 0.933
202406 0.813 314.175 0.817
202409 0.878 315.301 0.879
202412 0.739 315.605 0.739

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $6.52 mean?
Psychemedics (PMDI) has a Cyclically Adjusted Revenue per Share of $6.52 as of Dec. 2024. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Psychemedics and its competitors.
Is Psychemedics' Cyclically Adjusted Revenue per Share too high?
Psychemedics' current Cyclically Adjusted Revenue per Share is $6.52. Overall, Psychemedics has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Psychemedics' Cyclically Adjusted Revenue per Share compare to MBAI and MYNZ?
Psychemedics' Cyclically Adjusted Revenue per Share of $6.52 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Psychemedics and its competitors. Psychemedics's current Cyclically Adjusted Revenue per Share is $6.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Psychemedics stock overvalued right now?
Psychemedics (PMDI) has a current Cyclically Adjusted Revenue per Share of $6.52. The current Cyclically Adjusted Revenue per Share is $6.52. Psychemedics' overall GF Score™ is 58/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Psychemedics (PMDI), the current Cyclically Adjusted Revenue per Share is $6.52 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Psychemedics Business Description

Address 5220 Spring Valley Road, Suite 230, Dallas, TX, USA, 75254
Psychemedics Corp provides testing services for the detection of drug abuse and other health markers through the analysis of hair samples. The company generates revenue mainly from providing drug and alcohol testing services for its customers for an agreed-upon fee per unit tested. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in it without destroying the drugs. Geographically, the majority of its revenue comes from the United States, and also has a presence in other markets.
58GF Score

Get the complete analysis for PMDI

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.49
Price